Allen Davidoff
Company: XORTX Therapeutics Inc.
Job title: Chief Executive Officer
Seminars:
Intersection of Emerging Genetic Evidence for Accelerated Disease Progression & a Late-Stage Clinical Candidate for a Novel Preclinical Candidate for Rare & Genetic Kidney Disease 10:30 am
Discovering the genetic background and new alleles influencing ADPKD Demonstrating aberrant purine metabolism and exploring preclinical model data Discussing the path forwardRead more
day: Conference Day Two